These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10482146)

  • 41. Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.
    Steinhubl SR; Topol EJ
    J Thromb Thrombolysis; 1999 Jun; 7(3):227-31. PubMed ID: 10373712
    [No Abstract]   [Full Text] [Related]  

  • 42. Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management.
    Lablanche JM; McFadden EP; Bonnet JL; Grollier G; Danchin N; Bedossa M; Leclercq C; Vahanian A; Bauters C; Van Belle E; Bertrand ME
    Eur Heart J; 1996 Sep; 17(9):1373-80. PubMed ID: 8880023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
    Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
    Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
    Kozuma K; Hara K; Yamasaki M; Morino Y; Ayabe S; Kuroda Y; Tanabe K; Ikari Y; Tamura T
    Am Heart J; 2001 Jan; 141(1):124-30. PubMed ID: 11136497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation.
    Nakamura S; Hall P; Gaglione A; Tiecco F; Di Maggio M; Maiello L; Martini G; Colombo A
    J Am Coll Cardiol; 1997 Jan; 29(1):21-7. PubMed ID: 8996290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).
    Stefanescu Schmidt AC; Kereiakes DJ; Cutlip DE; Yeh RW; D'Agostino RB; Massaro JM; Hsieh WH; Mauri L;
    Circulation; 2017 May; 135(18):1720-1732. PubMed ID: 28228427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
    Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial.
    Lee CW; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Han S; Lee SG; Seong IW; Rha SW; Jeong MH; Lim DS; Yoon JH; Hur SH; Choi YS; Yang JY; Lee NH; Kim HS; Lee BK; Kim KS; Lee SU; Chae JK; Cheong SS; Suh IW; Park HS; Nah DY; Jeon DS; Seung KB; Lee K; Jang JS; Park SJ
    Circulation; 2014 Jan; 129(3):304-12. PubMed ID: 24097439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of cilostazol and clopidogrel after successful coronary stenting.
    Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ
    Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
    Chen YD; Lu YL; Jin ZN; Yuan F; Lü SZ
    Chin Med J (Engl); 2006 Mar; 119(5):360-6. PubMed ID: 16542577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiplatelet treatment with cilostazol after stent implantation.
    Yoshitomi Y; Kojima S; Sugi T; Yano M; Matsumoto Y; Kuramochi M
    Heart; 1998 Oct; 80(4):393-6. PubMed ID: 9875121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
    Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
    JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen.
    Schühlen H; Kastrati A; Pache J; Dirschinger J; Schömig A
    Am J Cardiol; 2001 Feb; 87(4):397-400. PubMed ID: 11179521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study.
    Jeong YH; Park Y; Muse WC; Kwon TJ; Koh JS; Hwang SJ; Kwak CH; Hwang JY
    J Thromb Haemost; 2012 Aug; 10(8):1685-8. PubMed ID: 22612904
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of Cilostazol versus Clopidogrel in Addition to Aspirin in Patients with Ischemic Stroke who Underwent Intracranial or Extracranial Artery Stent Implantation.
    Liu H; Shao T; Yang T; Li D; Wang H; Cheng Y; Zhang T; Zhang J
    J Atheroscler Thromb; 2023 Aug; 30(8):1010-1021. PubMed ID: 36328566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study.
    Min PK; Jung JH; Ko YG; Choi D; Jang Y; Shim WH
    Circ J; 2007 Nov; 71(11):1685-90. PubMed ID: 17965485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction.
    Xu LX; Chen KY; Liu T; Zheng XT; Jiao ZQ; Xu Y; Li G
    Cardiovasc Ther; 2016 Aug; 34(4):225-33. PubMed ID: 27133311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of cilostazol on clinical and angiographic outcome after primary stenting for acute myocardial infarction.
    Ochiai M; Eto K; Takeshita S; Yokoyama N; Oshima A; Kondo K; Sato T; Isshiki T
    Am J Cardiol; 1999 Nov; 84(9):1074-6, A6, A9. PubMed ID: 10569666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
    Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis.
    Xue Y; Feng ZW; Li XY; Hu ZH; Xu Q; Wang Z; Cheng JH; Shi HT; Wang QB; Wu HY; Xie XQ; Lv QZ
    Acta Pharmacol Sin; 2018 Feb; 39(2):205-212. PubMed ID: 28933424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.